FDA Approves First-Ever Frostbite Treatment Option For Adults

It was said the new medication option provides physicians with a tool that will help prevent the life-changing amputation of one's frostbitten limbs.

Wednesday the FDA approved the first-ever treatment option for frostbite in adults.

Aurlumyn injection can help reduce the risk of finger or toe amputation.

The active ingredient in the treatment is Iloprost, which prevents blood from clotting, showcasing efficacy in treating frostbite patients.

It was said the new medication option provides physicians with a tool that will help prevent the life-changing amputation of one’s frostbitten limbs.

Aurlumyn was approved after a trial involving 47 adults with severe frostbite delivered positive results.